North Carolina
NC Medicaid is receiving reports of pharmacists not utilizing the 72-hour Emergency Supply Override and the 01-No Other Coverage Identified code when applicable. Resistance to use these overrides is preventing Medicaid beneficiaries from being able to access necessary medications. As NC Medicaid providers, pharmacists are asked to please become familiar with these options and utilize them appropriately when administering the Medicaid benefit.
Pharmacists are asked to utilize the 72-Hour Emergency Supply Override when clinically appropriate for Medications pending Prior Authorization. For Medicaid members, including Medicaid Managed Care, Pharmacy providers are encouraged to use the 72-hour emergency supply allowed for drugs requiring prior approval. Federal law requires that this emergency supply be available to Medicaid beneficiaries for drugs requiring prior approval (Social Security Act, Section 1927, 42 U.S.C. 1396r-8(d)(5)(B)). Use of this emergency supply ensures access to medically necessary medications. With use of the override, the system will bypass the prior approval requirement, if an emergency supply is indicated. The pharmacist should use a "3" in the Level of Service field (418-DI) to indicate the transaction is an emergency fill. * Copayments apply to emergency fills and drug cost is reimbursed; however, a dispensing fee is not paid. There is no limit to the number of times the emergency supply can be used. *Codes may vary by managed care plan. This is the specific code for Medicaid Direct.
Pharmacists are asked to utilize the "01-No Other Coverage Identified" when a Medicaid claim rejects due to another payor on record. Medicaid is the payer of last resort, which means after any other insurance pays, Medicaid will pay. The other third-party payer must be billed as the primary payor when third party insurance exists, and then Medicaid can be billed as the secondary payor. When a claim is denied due to another payor on record being expired or terminated, the point-of-sale system will deny the claim, and the pharmacist will be prompted to submit the claim to another payer. In the event a beneficiary cannot produce another insurance or the beneficiary states they no longer have the other insurance, the pharmacy shall use the override code "01 – No Other Coverage Identified" in the Other Coverage Code claim segment 308-C8 for NCPDP D.0 transaction. * NC Medicaid will pay the pharmacy and seek payment from the third party, if appropriate. The pharmacy is not held liable for any payments made in these cases. *Codes may vary by managed care plan. This is the specific code for Medicaid Direct.
Thank you for your time and attention to this valuable information regarding the NC Medicaid Pharmacy Benefit. If you have any questions or concerns with the utilization of these override codes, please contact Angela Smith, Director NC Medicaid Pharmacy Benefit, or the Managed Care Plans directly.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Ohio
The Department of Medicaid (ODM) announced the timeline for upcoming "catch up" payments of the managed care "supplemental" dispensing fee to pharmacies along with a revised FAQ with further detail on the amount of the payments and formula for determining which payment tier your company will receive. Members will recall that these payments, which pharmacies have been receiving over the last few years, were delayed in the first quarter of 2022 while awaiting CMS approval.
Also In Ohio, on March 11 ODM is hosting an online seminar for pharmacies to give further details about the upcoming contracting process with their new SPBM (Single Pharmacy Benefit Manager), Gainwell Technology. Click here to register.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
South Carolina
Governor Henry McMaster issued Executive Order 2022-10 to suspend certain commercial vehicle regulations and provide transportation waivers to address the continued supply chain disruptions. The Governor’s executive order waives or suspends enforcement of certain state and federal regulations pertaining to registration, permitting and size. The read the full Executive Order click here
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Tennessee
Please see the updates to PDL, Clinical Criteria, and Interim Criteria below and the attached documents for March 2022. These changes went into effect on March 1st.
- Added to preferred: dimethyl fumarate, Dexilant, SPS,
- Added to non-preferred: Tecfidera, Tecfidera starter pack, dexlansoprazole, Dhivy, ciprofloxacin/dexamethasone, Epclusa pellet, Mavyret pellet
- Added to interim: Rezurock, Vuity, Voxzogo,
- BaG additions: Dexilant
- BaG removals: Tecfidera, Tecfidera starter pack
- Hepatic C Direct Acting Antivirals prior authorization criteria and PA forms: removal of restrictions surrounding prior history of substance or alcohol abuse, where applicable, removed questions related to pregnancy, concomitant ribavirin use, and renal function dosage adjustments.
Additionally, these documents can be found on the TennCare website: www.optumrx.com/tenncare
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Virginia
The Pharmacy Channel Team at the Department of Health have published a recent version of the Vaccine Standing Order, which reflects recent CDC updates on COVID-19 vaccination guidance with additional information to help vaccinators determine the optimal interval between the first and second dose of an mRNA vaccine series, based on the individual patient.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Washington
The 60-day legislative session ends on March 10th.
Also in Washington, the Health Care Authority (HCA) will submit to Centers for Medicare & Medicaid Services by July 15, 2022, a request to renew the Section 1115 Medicaid demonstration waiver, called the Medicaid Transformation Project (MTP), which will allow the state to create and continue to develop projects, activities, and services that improve Washington's health care system using federal Medicaid funding. The new proposals include:
- Continuous Medicaid enrollment for children
- Extending coverage for postpartum services
- Re-entry services for individuals who are exiting jail, prison, or other correctional facility
- Enhancements to long-term services and support (LTSS)
Finally in Washington, the Health Care Authority (HCA) aimed at increasing health care cost transparency and controlling health care cost growth include:
- The Health Care Cost Transparency Board is focusing on reducing health care cost growth and increasing price transparency.
- Prescription drug price transparency focuses on creating an annual report on how prescription drugs affect health care costs.
- The Washington State All Payer Claims Database (WA-APCD) is a tool used to collect health care claims data for reporting, analytics, and to help the public make their health care decisions. The WA-APCD supports health care and payment reform while addressing the need for cost, quality, and utilization transparency.
- Value-based purchasing (VBP) helps us achieve a healthier Washington by containing costs while improving outcomes, patient and provider experience, and equity.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Wisconsin
Wisconsin Medicaid, ForwardHealth, has released an update on coverage of at-home COVID tests for Medicaid patients. As a reminder, Pharmacies must submit a claim for these tests as a prescription. There is a standing order in place from the Department of Health Services (DHS) Chief Medical Officer Dr. Ryan Westerguard. The pharmacists may order the tests and patients may receive 8 tests per 30-day period.
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
Alaska
New rules relating to the Prescription Drug Monitoring Program (PDMP) go into effect on March 17, 2022. The regulations clarify the registration process to align with the account creation steps at alaska.pmpaware.net, replaces “registration” with “designation,” and establishes a new requirement for pharmacists and pharmacies to notify the board within 10 days of a change in dispensing/distributing status of controlled substances. The forms will be available in the coming weeks at pharmacy.alaska.gov.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
California
The Department of Health Care Services posted the following alerts to the Medi-Cal Rx Web Portal:
- Clarification of Temporary Prior Authorization (PA) Policy Change (February 21)
- Medi-Cal Rx Drug Lookup Tool and Contract Drugs List Tips (February 24)
- Medi-Cal Rx Provider Portal Troubleshooting and Support (February 24)
- Remdesivir (Veklury) for Outpatient Treatment of COVID-19 (February 24)
- Required Documentation for Claim and Prior Authorization Support (February 24)
Also in California, COVID-19 related news highlighted below:
- Governor Newsom Unveils SMARTER Plan Charting California's Path Forward on Nation-Leading Pandemic Response
- California SMARTER – The Next Phase of California's COVID-19 Response
- County of Los Angeles Department of Public Health Order of the Health Officer (Revised February 23, 2022)
Finally in California, the Department of Health Care Services is proposing a budget trailer bill language to require Medi-Cal pharmacy providers to maintain records for ten years, consistent with federal law. The current requirement in the state is three years. DHCS prepared this fact sheet about the proposal.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Colorado
Health First Colorado is paying for up to 15 COVID-19 home tests per member each month when provided by an enrolled pharmacy.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
District of Columbia
Medicaid has scheduled the virtual quarterly pharmacy forum on March 15 from 1-2pm and March 16 from 10-11:30 pm and are “highly encouraging” attendance. Click here to RSVP and receive the log in information.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Illinois
The Illinois Department of Human Services reports pharmacies and grocer/pharmacies may see an increase in demand for Neocate formula and nutritionals with the recent recall of Abbott's EleCare and EleCare Junior products. Some participants who were prescribed EleCare have had their prescriptions adjusted and will now be coming to pharmacies with requests for Neocate products.
Click here for a copy of the IDHS Notice. For ordering information click here
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Indiana
The Department of Health (IDOH) and the Health Coverage Programs (IHCP) announced that they are making changes to the Vaccines for Children (VFC) policy to allow pharmacies to easily enroll in the program, effective March 14, 2022. The maximum allowable reimbursement for the administration of a VFC vaccine will be consistent with reimbursement for vaccines administered by medical providers, which is currently $15.00.
Also in Indiana, effective February 1, 2022, IHCP began reimbursing pharmacies for dispensing FDA approved COVID19 test kits at home, with a limit of two tests per 7 days per member under a statewide standing order.
Also in Indiana, the Indiana Family and Social Services Administration's (FSSA) Office of Medicaid Policy and Planning provided updates to the opioid utilization prior authorization (PA) criteria's maximum allowable daily morphine milligram equivalent (MME) effective for claims with dates of service (DOS) on or after April 1, 2022.
Finally in Indiana, HB 1158, legislation that would allow a pharmacy technician to administer any vaccines delegated by a pharmacist, passed the House and is pending in the Senate Health and Provider Services Committee.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Iowa
The Department of Human Services published the following:
- INFORMATIONAL LETTER NO. 2314-MC-FFS-CVD: This informational letter provides guidance to providers on billing for COVID-19 OTC home testing. This policy will remain in effect for the duration of the public health emergency.
- INFORMATIONAL LETTER NO. 2315-MC-FFS-CVD: On February 3, Gov. Kim Reynolds (R) signed the final extension to the state's Public Health Disaster Emergency Proclamation that announced the Public Health Disaster Emergency would expire on February 15 at 11:59 p.m. Please note: The end of the state's Public Health Disaster Emergency does not impact Medicaid flexibilities currently in place.
Also in Iowa, the Board of Pharmacy will meet on March 1 via Zoom and in-person; the meeting agenda has been posted.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Kansas
HB 200, legislation expanding the pharmacist's scope of practice to include initiation of therapy for influenza, strep throat and urinary tract infection pursuant to a statewide protocol adopted by the collaborative drug therapy management advisory committee, passed the Senate by a vote of 37-2. It was referred to the House Health and Human Service Committee for further action.
Also in Kansas, legislation that would establish a joint committee on pharmacy workplace conditions and patient safety to conduct a study and issue a report to the legislature was referred to the House Health and Human Services Committee. HB 2698
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Louisiana
The Board of Pharmacy unanimously approved supporting filing legislation on collaborative practice agreements, statewide protocols for patient care services, requiring PBM licensing and a bill that would add pharmacy interns and certified pharmacy technicians as authorized immunizers, and reducing the age threshold from 7 to 3 years and older for influenza immunizations and from 17 to 3 years and older for all other immunizations. The legislature convenes on March 14th.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Michigan
Governor Gretchen Whitmer (D) signed into law on February 23 three bills — HB 4348, HB 4351, and HB 4352 aimed at lowering the costs of prescription drugs, ensure that pharmacists can provide advice to patients about treatment options, and provide oversight and transparency for pharmacy benefit managers. The laws will require that PBMs be licensed with the Department of Insurance and Financial Services. In addition, the legislation provides government oversight on pharmacy audits and appeals with help from state regulators. The law takes effect January 1, 2024
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
Minnesota
The Department of Health has published a weekly covid vaccine providers report. To subscribe to it click here.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Nebraska
The Department of Health and Human Services announced the next COVID-19 Medicaid Provider call will take place on March 2 at noon (Central).
Also in Nebraska, the Department of Health and Human Services has posted the DUR (Drug Utilization Review) Board March 8 meeting agenda and DUR Policy Statements (as of July 2021).
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
New Hampshire
The Board of Pharmacy has proposed to adopt regulations to establish requirements for automated pharmacy systems in community long-term care facilities, hospices, state and county correctional institutions, and hospitals. A hearing is scheduled for March 18,2022 in Concord.
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
New Mexico
Gov. Michelle Lujan Grisham (D) announced February 17th that effective immediately, masks will no longer be required indoors, except for in hospitals, assisted living centers, certain health care settings, as well as in state correctional and juvenile justice facilities.
Also in New Mexico, the Legislature adjourned the 30-day fiscal session on February 17th.
Finally in New Mexico, to better combat the opioid crisis, legislators passed HB 52 which will decriminalize the possession of fentanyl test strips. Gov. Michelle Lujan Grisham (D) has until March 9, 2022, to sign the bill into law.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
New York
The NYS Department of Health has updated COVID guidance documents including:
- Guidance for the New York State COVID-19 Vaccination Program for Individuals 12 Years of Age and Older
- Information for Health Care Professionals about the Screening Checklist for the COVID-19 Vaccine: Individuals 12 Years of Age and Older
- Guidance for the New York State COVID-19 Vaccination Program: Vaccination of Children Ages 5-11
- Information for Health Care Professionals about the Screening Checklist for Administration of the Pfizer-BioNTech COVID-19 Vaccine for Children Ages 5-11
- Information for Health Care Professionals about the Screening Checklist for the COVID-19 Vaccine: Additional Dose for Moderately to Severely Immunocompromised People
- COVID-19 Immunization Screening and Consent Form: Additional Dose for Moderately to Severely Immunocompromised People
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
North Carolina
The Board's revised centralized pharmacy services rule has cleared final review. The chief change achieved by the amendments is to broaden the availability of remote medication order processing from the health-system practice setting to all pharmacy practice settings.
Even though the amended rule is effective March 1, 2022, several implementation tasks need to be completed. Chief among them: Board staff need to program a registration system for out-of-state pharmacists who are not licensed in North Carolina, but who intend to provide RMOE services to North Carolina pharmacies by obtaining an NABP (National Association of Boards of Pharmacy) Verify credential. NABP staff are implementing the NABP Verify credential application process. Board staff expect both steps to be completed by April 1, 2022.
In the meantime, North Carolina pharmacies who have implemented RMOE systems under the Board's emergency services waiver may continue to use them. The Board will ensure that pharmacies that have deployed waiver-based RMOE operations have reasonable time and opportunity to transfer to rule-based operations. The full Board will discuss implementation at its March 8, 2022, meeting.
In the coming weeks, Board staff will also publish a detailed FAQ document on the revised centralized pharmacy services rule.
Pharmacists are reminded that the Board is proceeding with additional rulemaking to permanently authorize North Carolina pharmacy personnel to perform remote work (other than physical acts in the dispensing process) for their employing pharmacy. North Carolina pharmacies who have implemented waiver-based remote work systems in North Carolina may continue to use them while this rulemaking proceeds. More information on this proposed rule is found here.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Ohio
HB 37, a bill that NACDS and the Ohio Council of Retail Merchants jointly supported, has passed both Chambers and is on its way to the Governor for signature. Sponsored by Rep. Gayle Manning (R), it authorizes pharmacists to dispense emergency refills three times a year and requires health insurers to cover these prescriptions.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Oklahoma
The Pharmacy Board will be moving to a temporary location while the office building is being renovated. The office will be down during the move, from February 28 the to March 4th. The new address is 3812 N. Santa Fe Suite 300, Oklahoma City, OK 73118.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
